Showing 21-30 of 38 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| BimT1D | The University of British Columbia | Jan Dutz | Cures | 01-September-2025 to 31-August-2029 | $2,488,315.00 |
| Clinical Phase II/III Trial to treat type 1 diabetes (UST1D2) | The University of British Columbia | Jan Dutz | Cures | 01-November-2020 to 31-December-2027 | $538,854.00 |
| Engineering Stem Cell-Derived Islet Organoids with Immune Protection and Enhanced Vascular Support for Functional Cure of Diabetes | The University of British Columbia | Jia Zhao | Cures | 01-March-2026 to 28-February-2029 | $285,000.00 |
| Modulation of immune cell fate and function by the islet secretome in health and diabetes | The University of British Columbia | Lauar de Brito Monteiro | Cures | 01-March-2024 to 28-February-2027 | $243,055.00 |
| Harmonizing biomarkers in clinical trials of ustekinumab | The University of British Columbia | Megan Levings | Cures | 01-July-2018 to 30-June-2027 | $660,059.94 |
| RREB1 and Ras signalling in cytokine-induced beta cell death | The University of British Columbia | Nicole Krentz | Cures | 01-March-2026 to 28-February-2031 | $1,000,000.00 |
| Implementing a virtual care platform to improve mental health for type 1 diabetes in rural and remote regions of Interior British Columbia | The University of British Columbia | Tricia Tang | Improving Lives | 01-April-2020 to 30-January-2026 | $393,786.60 |
| Using a virtual care platform to deliver peer-led mental health support to rural and remote communities in BC: A randomized wait-list controlled trial of the REACHOUT intervention | The University of British Columbia | Tricia Tang | Improving Lives | 01-September-2022 to 31-December-2026 | $402,429.50 |
| Feasibility Studies and Process Development with Clinical-Grade iPSC lines to Establish a Beta Cell Biomanufacturing Facility | University Health Network | Maria Cristina Nostro | Cures | 01-May-2025 to 30-April-2026 | $1,289,484.76 |
| Immune evasive islet-like cells by reduced immune recognition and local immune control | University Health Network | Maria Cristina Nostro | Cures | 01-June-2024 to 31-May-2027 | $999,509.50 |